HUE052613T2 - Humán C5 komplementhez kötõdõ stabil polipeptidek - Google Patents

Humán C5 komplementhez kötõdõ stabil polipeptidek

Info

Publication number: HUE052613T2
Authority: HU; Hungary
Prior art keywords: complement; bind; human; stable polypeptides; polypeptides
Prior art date: 2013-08-28

Application number

HUE14765883A

Other languages

English (en)

Inventor

Joakim Nilsson

Erik Nordling

Patrik Stroemberg

Original Assignee

Ipc Res Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-28

Filing date

2014-08-28

Publication date

2021-05-28

2014-08-28 Application filed by Ipc Res Llc filed Critical Ipc Res Llc

2021-05-28 Publication of HUE052613T2 publication Critical patent/HUE052613T2/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Immunology (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)

HUE14765883A 2013-08-28 2014-08-28 Humán C5 komplementhez kötõdõ stabil polipeptidek HUE052613T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE1350986		2013-08-28

Publications (1)

Publication Number	Publication Date
HUE052613T2 true HUE052613T2 (hu)	2021-05-28

Family

ID=51539238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUE14765883A HUE052613T2 (hu)	2013-08-28	2014-08-28	Humán C5 komplementhez kötõdõ stabil polipeptidek

Country Status (29)

Country	Link
US (1)	US9994626B2 (hu)
EP (2)	EP3038633B1 (hu)
JP (2)	JP6767865B2 (hu)
KR (1)	KR102446636B1 (hu)
CN (1)	CN105658228B (hu)
AU (1)	AU2014314222B2 (hu)
BR (1)	BR112016003142A2 (hu)
CA (1)	CA2926976C (hu)
CY (1)	CY1123732T1 (hu)
DK (1)	DK3038633T3 (hu)
ES (1)	ES2842105T3 (hu)
HR (1)	HRP20210013T1 (hu)
HU (1)	HUE052613T2 (hu)
IL (1)	IL244218A (hu)
LT (1)	LT3038633T (hu)
MX (1)	MX382140B (hu)
MY (1)	MY173804A (hu)
NZ (1)	NZ718153A (hu)
PH (1)	PH12016500371B1 (hu)
PL (1)	PL3038633T3 (hu)
PT (1)	PT3038633T (hu)
RS (1)	RS61347B1 (hu)
RU (2)	RU2020128977A (hu)
SA (1)	SA516370622B1 (hu)
SG (1)	SG11201602679VA (hu)
SI (1)	SI3038633T1 (hu)
SM (1)	SMT202100006T1 (hu)
UA (1)	UA117933C2 (hu)
WO (1)	WO2015028558A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS58503B1 (sr)	2012-02-20	2019-04-30	Swedish Orphan Biovitrum Ab Publ	Polipeptidi koji se vezuju za humani komplement c5
MX367423B (es) *	2013-08-28	2019-08-21	Affibody Ab	Polipeptidos de union a c5.
LT3038633T (lt) *	2013-08-28	2021-03-25	Ipc Research, Llc	Stabilūs polipeptidai, kurie rišasi prie žmogaus komplemento c5
UY37651A (es) *	2017-03-31	2018-10-31	Swedish Orphan Biovitrum Ab Publ	Polipéptido de unión al il-1r-i
CN117327188A (zh)	2017-07-11	2024-01-02	亚力兄制药公司	结合补体成分c5或血清白蛋白的多肽及其融合蛋白
WO2022171892A1 (en) *	2021-02-15	2022-08-18	Affibody Ab	New her2-binding polypeptide
KR20240134857A (ko) *	2021-11-01	2024-09-10	아이피씨 리써치, 엘엘씨	C5-결합 단백질 투여
WO2024227886A1 (en)	2023-05-02	2024-11-07	Mebrahtu Aman	Bispecific binding molecule

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE509359C2 (sv)	1989-08-01	1999-01-18	Cemu Bioteknik Ab	Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US6074642A (en)	1994-05-02	2000-06-13	Alexion Pharmaceuticals, Inc.	Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
CA2424379C (en)	2000-10-10	2013-10-01	Tanox, Inc.	Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
AT410798B (de) *	2001-01-26	2003-07-25	Cistem Biotechnologies Gmbh	Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
CN100391537C (zh)	2001-08-17	2008-06-04	建南德克公司	结合至c5和c5a但不阻止c5b形成的补体途径抑制剂
ITMI20021527A1 (it)	2002-07-11	2004-01-12	Consiglio Nazionale Ricerche	Anticorpi anti componente c5 del complemento e loro uso
EP1667702A2 (en)	2003-09-10	2006-06-14	Baxter International Inc., Baxter Healthcare Corp.	Peptides that inhibit complement activation
SE0400274D0 (sv) *	2004-02-09	2004-02-09	Affibody Ab	New polypeptide
GB0518443D0 (en) *	2005-09-09	2005-10-19	Evolutec Ltd	Method of treating myasthenia gravis
DK1991275T3 (en) *	2006-03-08	2014-12-08	Archemix Llc	Complement aptamers AND ANTI-C5 AGENTS FOR USE IN THE TREATMENT OF EYE DISEASES
HUE066795T2 (hu) *	2006-03-15	2024-09-28	Alexion Pharma Inc	Paroxysmalis nocturnalis haemoglobinuriában szenvedõ betegek kezelése egy komplement inhibitorral
US8937153B2 (en)	2007-07-31	2015-01-20	Affibody Ab	Compositions, methods and uses
DK2231860T3 (da) *	2007-12-19	2011-12-05	Affibody Ab	Polypeptid afledt protein A og i stand til at binde PDGF
US9187535B2 (en)	2007-12-19	2015-11-17	Affibody Ab	Polypeptide derived from protein A and able to bind PDGF
EP2072525A1 (en)	2007-12-21	2009-06-24	Affibody AB	New polypeptides having affinity for HER2
MX2011001371A (es)	2008-08-05	2011-06-16	Novartis Ag	Composiciones y metodos para anticuerpos que se dirigen a la proteina de complementos c5.
EP2327725A1 (en)	2009-11-26	2011-06-01	InflaRx GmbH	Anti-C5a binding moieties with high blocking activity
WO2012004384A2 (en)	2010-07-09	2012-01-12	Affibody Ab	Polypeptides
RS58503B1 (sr) *	2012-02-20	2019-04-30	Swedish Orphan Biovitrum Ab Publ	Polipeptidi koji se vezuju za humani komplement c5
JP5980104B2 (ja)	2012-11-22	2016-08-31	三菱電機株式会社	液晶表示装置の製造方法および液晶表示装置の製造システム
EP2935335B1 (en)	2012-12-19	2020-10-28	Affibody AB	New polypeptides
MX367423B (es) *	2013-08-28	2019-08-21	Affibody Ab	Polipeptidos de union a c5.
LT3038633T (lt) *	2013-08-28	2021-03-25	Ipc Research, Llc	Stabilūs polipeptidai, kurie rišasi prie žmogaus komplemento c5

2014
- 2014-08-28 LT LTEP14765883.5T patent/LT3038633T/lt unknown
- 2014-08-28 RU RU2020128977A patent/RU2020128977A/ru unknown
- 2014-08-28 RS RS20210005A patent/RS61347B1/sr unknown
- 2014-08-28 MX MX2016002397A patent/MX382140B/es unknown
- 2014-08-28 SI SI201431739T patent/SI3038633T1/sl unknown
- 2014-08-28 MY MYPI2016700583A patent/MY173804A/en unknown
- 2014-08-28 CN CN201480057470.XA patent/CN105658228B/zh active Active
- 2014-08-28 BR BR112016003142A patent/BR112016003142A2/pt not_active Application Discontinuation
- 2014-08-28 JP JP2016537298A patent/JP6767865B2/ja active Active
- 2014-08-28 EP EP14765883.5A patent/EP3038633B1/en active Active
- 2014-08-28 PT PT147658835T patent/PT3038633T/pt unknown
- 2014-08-28 SM SM20210006T patent/SMT202100006T1/it unknown
- 2014-08-28 DK DK14765883.5T patent/DK3038633T3/da active
- 2014-08-28 EP EP20201264.7A patent/EP3811961B1/en active Active
- 2014-08-28 HU HUE14765883A patent/HUE052613T2/hu unknown
- 2014-08-28 WO PCT/EP2014/068282 patent/WO2015028558A1/en not_active Ceased
- 2014-08-28 US US14/914,290 patent/US9994626B2/en active Active
- 2014-08-28 UA UAA201603124A patent/UA117933C2/uk unknown
- 2014-08-28 KR KR1020167007498A patent/KR102446636B1/ko active Active
- 2014-08-28 HR HRP20210013TT patent/HRP20210013T1/hr unknown
- 2014-08-28 NZ NZ718153A patent/NZ718153A/en unknown
- 2014-08-28 AU AU2014314222A patent/AU2014314222B2/en active Active
- 2014-08-28 ES ES14765883T patent/ES2842105T3/es active Active
- 2014-08-28 CA CA2926976A patent/CA2926976C/en active Active
- 2014-08-28 PL PL14765883T patent/PL3038633T3/pl unknown
- 2014-08-28 SG SG11201602679VA patent/SG11201602679VA/en unknown
- 2014-08-28 RU RU2016111115A patent/RU2733897C2/ru active
2016
- 2016-02-22 IL IL244218A patent/IL244218A/en active IP Right Grant
- 2016-02-24 PH PH12016500371A patent/PH12016500371B1/en unknown
- 2016-02-25 SA SA516370622A patent/SA516370622B1/ar unknown
2020
- 2020-07-01 JP JP2020113725A patent/JP2020172505A/ja active Pending
- 2020-12-30 CY CY20201101229T patent/CY1123732T1/el unknown

Also Published As

Publication number	Publication date
PH12016500371A1 (en)	2016-05-02
EP3811961B1 (en)	2025-08-20
SA516370622B1 (ar)	2018-12-23
PL3038633T3 (pl)	2021-07-19
UA117933C2 (uk)	2018-10-25
SG11201602679VA (en)	2016-05-30
JP6767865B2 (ja)	2020-10-14
EP3038633B1 (en)	2020-10-14
NZ718153A (en)	2022-05-27
MY173804A (en)	2020-02-24
LT3038633T (lt)	2021-03-25
KR102446636B1 (ko)	2022-09-23
US9994626B2 (en)	2018-06-12
AU2014314222A1 (en)	2016-04-21
BR122023020080A2 (pt)	2023-12-26
CA2926976C (en)	2023-11-28
JP2016529270A (ja)	2016-09-23
CN105658228A (zh)	2016-06-08
HK1225656A1 (en)	2017-09-15
RU2016111115A3 (hu)	2018-04-25
MX382140B (es)	2025-03-13
CA2926976A1 (en)	2015-03-05
RU2020128977A (ru)	2021-11-30
SI3038633T1 (sl)	2021-05-31
WO2015028558A1 (en)	2015-03-05
PH12016500371B1 (en)	2016-05-02
RS61347B1 (sr)	2021-02-26
JP2020172505A (ja)	2020-10-22
EP3811961A1 (en)	2021-04-28
US20160311870A1 (en)	2016-10-27
DK3038633T3 (da)	2021-01-11
MX2016002397A (es)	2016-09-08
SMT202100006T1 (it)	2021-03-15
KR20160048121A (ko)	2016-05-03
IL244218A (en)	2017-11-30
IL244218A0 (en)	2016-04-21
RU2016111115A (ru)	2017-10-03
CN105658228B (zh)	2020-02-07
RU2733897C2 (ru)	2020-10-09
AU2014314222B2 (en)	2018-05-24
BR112016003142A2 (pt)	2017-10-17
ES2842105T3 (es)	2021-07-12
HRP20210013T1 (hr)	2021-04-02
EP3038633A1 (en)	2016-07-06
PT3038633T (pt)	2021-01-14
CY1123732T1 (el)	2021-10-29

Publication	Publication Date	Title
UA30924S (uk)	2015-12-10	Контейнер для косметичного засобу
EP2889350A4 (en)	2016-05-18	ADHESIVE COMPOSITION
PL2817329T3 (pl)	2019-07-31	Polipeptydy wiążące z c5 ludzkiego dopełniacza
DK3385545T3 (da)	2024-01-29	Forbindelsesorgan
DK3027750T3 (da)	2019-07-15	Biokatalytisk sammensætning
HUE052613T2 (hu)	2021-05-28	Humán C5 komplementhez kötõdõ stabil polipeptidek
DK2956010T4 (da)	2023-01-09	Fedtsammensætning
EP2873719A4 (en)	2015-08-26	GREASE COMPOSITION
ES1081530Y (es)	2013-09-02	Lavacabezas sanitario multifuncional
DK3089990T3 (da)	2020-08-24	Forbedret proteinekspression
DK3057450T3 (da)	2019-09-23	Fødevaresammensætning
DK3089991T3 (da)	2019-12-02	Forbedret proteinekspression
FR3014440B1 (fr)	2016-01-22	Polypeptides entomotoxiques
KR102216470B9 (ko)	2022-02-14	천연물 조성물
BR302013006674S1 (pt)	2014-06-24	Configuração aplicada em receptáculo
TH1501001889A (th)	2016-11-16	องค์ประกอบเครื่องสำอาง
TH1401003526B (th)	2016-07-28	องค์ประกอบเครื่องสำอาง
UA28340S (uk)	2014-11-10	Вмістина
UA28341S (uk)	2014-11-10	Вмістина
BR302013003405S1 (pt)	2014-12-23	Configuração aplicada em recipiente multi-alimentos
DK3082855T3 (da)	2021-05-25	Sammensætning
ES1087630Y (es)	2013-11-15	Escurridor de cubiertos-maceta
FI20135969L (fi)	2015-03-28	Jauhemainen hunaja
BR302013006073S1 (pt)	2015-03-10	Conjunto de talheres
EP2956112A4 (en)	2016-08-10	DENTAL COMPOSITION